Fondaparinux: A suitable alternative in cases of delayed-type allergy to heparins and semisynthetic heparinoids? A study of 7 cases

Contact Dermatitis

Volumn 51, Issue 2, 2004, Pages 67-72

  Jappe, Uta ^a   Juschka, U ^a   Kuner, N ^a   Hausen, B M ^b   Krohn, K ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF PADERBORN   (Germany)

Author keywords

Delayed type allergy; Fondaparinux allergy; Heparin; Heparinoids; Recombinant hirudin

Indexed keywords

CLIVARIN 1750; DALTEPARIN; DANAPAROID; ENOXAPARIN; FONDAPARINUX; HAPTEN; HEPARIN; HEPARINOID; LEPIRUDIN; LIQUEMIN N 5000; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; PENTASACCHARIDE; PENTOSAN POLYSULFATE; PROTEIN; REVIPARIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CROSS REACTION; DELAYED HYPERSENSITIVITY; DRUG PROTEIN BINDING; DRUG SAFETY; DRUG STRUCTURE; DRUG TOLERABILITY; FEMALE; HUMAN; HYPERSENSITIVITY; INTRACUTANEOUS TEST; MOLECULAR WEIGHT; PATHOGENESIS;

ADULT; AGED; ANTICOAGULANTS; CROSS REACTIONS; DERMATITIS, ALLERGIC CONTACT; FEMALE; HEPARIN; HUMANS; MIDDLE AGED; MOLECULAR STRUCTURE; POLYSACCHARIDES; SKIN TESTS;

EID: 4944222093     PISSN: 01051873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0105-1873.2004.00399.x     Document Type: Article

References (19)

1. Jappe U, Gollnick H. Allergy to heparin, heparinoids, and recombinant hirudin. Diagnostic procedures and alternative coagulants. Hautarzt 1999: 50: 406-411.
2. Funt S A, Hidalgo A, Panicek D M. Subcutaneous nodules at the injection site of low molecular weight heparin: a mimic of metastatic disease at CT. J Comput Assist Tomogr 2002: 26: 520-523.
3. Poza Guedez P. Different patterns of cross-reactivity in non-immediate hypersensitivity to heparins: from localized to systemic reactions. Contact Dermatitis 2003, 244-245.
4. Boehncke W-H, Weber L, Gall H. Tolerance to intravenous administration of heparin and heparinoid in a patient with delayed-type hypersensitivity to heparins and heparinoids. Contact Dermatitis 1996: 35: 73-75.
5. Jappe U, Reinhold D, Bonnekoh B. Arthus reaction to lepirudin, a new recombinant hirudin, and delayed-type hypersensitivity to several heparins and heparinoids, with tolerance to its intravenous administration. Contact Dermatitis 2002: 46: 29-32.
6. Greiner D, Schöfer H. Allergisches Arzneimittelexanthem auf Heparin. Kutane Reaktionen auf hochmolekulares und fraktioniertes Heparin. Hautarzt 1994: 45: 569-572.
7. Harenberg J, Huhle G, Wang L, Hoffmann U, Bayerl C, Kerowgan M. Association of heparin-induced skin lesions, intracutaneous tests, and heparin-induced IgG. Allergy 1999: 54: 473-477.
8. Uhle G, Gebereth M, Hoffmann U, Heene D L, Harenberg J. Management of heparin-associated thrombocytopenia in pregnancy with subcutaneous r-hirudin. Gynecol Obstet Invest 2000: 49: 67-69.
9. Lubenow N, Greinacher A. Heparin-induced thrombocytopenia. Recommendations for optimal use of recombinant hirudin. Biodrugs 2000: 14: 109-125.
10. Bircher A J, Czendlik Ch, Messmer S L, Muller P, Howald H. Acute urticaria caused by subcutaneous recombinant hirudin: evidence for an IgG-mediated hypersensitivity reaction. J Allergy Clin Immunol 1996: 98: 994-996.
11. Zollner T M, Gall H, Volpel H, Kaufmann R. Type IV allergy to natural hirudin confirmed by in vitro stimulation with recombinant hirudin. Contact Dermatitis 1996: 35: 59-60.
12. Greinacher A, Lubenow N, Eichler P. Anaphylactic and anaphylactoid reactions associated with lepirudin in patients with heparin-induced thrombocytopenia. Circulation 2003: 108: 2062-2065.
13. Close P, Bichler J, Kerry R. Weak allergenicity of recombinant hirudin CGP 39393 (Revasc) in immunocompetent volunteers. The European Hirudin in Thrombosis Group. Coron Artery Dis 1994: 5: 943-949.
14. Walenga J M, Jeske W P, Bara L, Samama M M, Fareed J. Biochemical and pharmaceutical rationale for the development of a synthetic heparin pentasaccharide. Thromb Res 1997: 86: 1-36.
15. Elalamy I, Lecrubier C, Potevin F et al. Absence of in vitro cross-reaction of pentasaccharide with plasma heparin dependent factor of twenty-five patients with heparin-associated thrombocytopenia. Thromb Haemost 1995: 74: 1384-1395.
16. Ludwig R J, Beier C, Lindhoff-Last E, Kaufmann R, Boehncke Wh. Tolerance of fondaparinux in a patient allergic to heparins and other glycosaminoglycans. Contact Dermatitis 2003: 49: 158-159.
17. Sacher A, Hunzelmann N. Tolerance to the synthetic pentasaccharide fondaparinux in heparin sensitisation. Allergy 2003: 58: 1318-1319.
18. Hirsch K, Ludwig R J, Lindhoff-Last E, Kaufmann R, Boehncke W-H. Intolerance of fondaparinux in a patient allergic to heparins. Contact Dermatitis 2004: 50: 383-384.
19. Hoffman-La Roche. Summary of the Product Characteristics for Liquemin N 5000, July. Germany: Hoffman-La Roche, 1995.